In support of this, TGFβ receptors and SMAD genes are intact in more than 60% of human CRCs [27], and cancer cell-intrinsic TGFβ pathway activity is evident in poor prognosis colorectal tumors [28, 30]. This evidence concerns the gene TGFB1 and cancer.